{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:03:51Z","timestamp":1788271431319,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["SA18I0039"],"award-info":[{"award-number":["SA18I0039"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer pain is one of the most frequent and relevant symptoms in cancer patients and impacts on patient\u2019s quality of life. International and local standards recommend as an initial strategy the use of an analgesic scheme composed of strong opioids associated with adjuvants such as acetaminophen, based upon the assumption that combining drugs could have a better analgesic effect, could allow lowering opioid dosing, and could prevent the occurrence of adverse effects of opioids. However, there is uncertainty about the impact of acetaminophen as an adjuvant in patients who use strong opioids for moderate to severe pain management in cancer patients. The aim of this study is to assess the efficacy and safety of intravenous acetaminophen associated with strong opioids in hospitalized adult cancer patients who have moderate to severe cancer-related pain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We will perform a randomized double-blinded controlled study comparing intravenous acetaminophen 1 g 4 times a day versus placebo for 48 h as an adjuvant to strong opioids. We will assess pain intensity as a primary outcome, using the verbal numerical rating scale (VNRS, I0 to 10 scale with higher scores meaning higher pain intensity), and we will compare the mean difference in pain intensity between baseline and 48 h among the placebo and intervention groups. We estimate that a decrease of 1 point in the VNRS would be clinically significant. Assuming a standard deviation in pain intensity of 1.7 points, an alpha of 0.025, and a power of 0.8, we estimate a sample size of 112 patients, with 56 patients in each arm. Secondary outcomes include the difference in total opioid use between baseline and at 48 h among the groups, and adverse effects such as drowsiness, constipation, nausea, and vomiting would be evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The randomized, double-blind, placebo-controlled design is the best strategy to assess the efficacy of acetaminophen as an adjuvant in adult cancer patients with moderate to severe pain who are receiving strong opioids. We expect to contribute to national and international guidelines with these results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Clinicaltrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04779567?term=acetaminophen&amp;cond=cancer+pain&amp;draw=2&amp;rank=2\">NCT04779567<\/jats:ext-link>. Registered on March 3, 2021. Retrospectively registered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06442-2","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T07:02:46Z","timestamp":1657090966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Randomized double-blind controlled trial to assess the efficacy of intravenous acetaminophen associated with strong opioids in the treatment of acute pain in adult cancer patients: study protocol"],"prefix":"10.1186","volume":"23","author":[{"given":"Ofelia","family":"Leiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz M.","family":"Letelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-6919","authenticated-orcid":false,"given":"Pedro","family":"Perez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"issue":"3","key":"6442_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.pain.2007.08.022","volume":"132","author":"MH Van den Beuken-van Everdingen","year":"2007","unstructured":"Van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain. 2007;132(3):312\u201320.","journal-title":"Pain"},{"issue":"1","key":"6442_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","volume":"34","author":"SC Teunissen","year":"2007","unstructured":"Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34(1):94\u2013104 Epub 2007 May 23. Review. PubMed ID: 17509812.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"6442_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1081\/CNV-50482","volume":"23","author":"LC Goudas","year":"2005","unstructured":"Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB. The epidemiology of cancer pain. Cancer Invest. 2005;23(2):182\u201390.","journal-title":"Cancer Invest"},{"key":"6442_CR4","doi-asserted-by":"publisher","unstructured":"Portenoy RK, Ahmed E. Principles of opioid use in cancer pain. J Clin Oncol. 2014;32(16):1662-70. doi: https:\/\/doi.org\/10.1200\/JCO.2013.52.5188. Epub 2014 May 5. Review. PubMed ID: 24799466.","DOI":"10.1200\/JCO.2013.52.5188"},{"key":"6442_CR5","volume-title":"Cancer pain relief","author":"Organization WH","year":"1986","unstructured":"Organization WH. Cancer pain relief. Geneva: World Health Organization; 1986."},{"key":"6442_CR6","volume-title":"WHO\u2019s cancer pain ladder for adults","author":"Organization WH","year":"2016","unstructured":"Organization WH. WHO\u2019s cancer pain ladder for adults. 2016. Available from: http:\/\/www.who.int\/cancer\/palliative\/painladder\/en\/."},{"issue":"23","key":"6442_CR7","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.1995.03530230056031","volume":"274","author":"AR Jadad","year":"1995","unstructured":"Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA. 1995;274(23):1870\u20133.","journal-title":"JAMA"},{"issue":"9","key":"6442_CR8","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","volume":"19","author":"N Cherny","year":"2001","unstructured":"Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19(9):2542\u201354.","journal-title":"J Clin Oncol"},{"issue":"4","key":"6442_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/0269216311428528","volume":"26","author":"M Nabal","year":"2012","unstructured":"Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med. 2012;26(4):305\u201312. https:\/\/doi.org\/10.1177\/0269216311428528 Epub 2011 Nov 29. Review. PubMed ID: 22126843.","journal-title":"Palliat Med"},{"issue":"7173","key":"6442_CR10","first-page":"1656","volume":"317","author":"S Bridger","year":"1998","unstructured":"Bridger S, Henderson K, Ellis AJ, Glucksman E, Williams R, Henry J. Deaths from low dose paracetamol poisoning - reply. Brit Med J. 1998;317(7173):1656\u20137.","journal-title":"Brit Med J"},{"key":"6442_CR11","doi-asserted-by":"crossref","unstructured":"Toms L, McQuay HJ, Derry S, Moore RA. Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev. 2008;2008(4):CD004602.","DOI":"10.1002\/14651858.CD004602.pub2"},{"issue":"4","key":"6442_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.arth.2016.10.018","volume":"32","author":"JR Politi","year":"2017","unstructured":"Politi JR, Davis RL 2nd, Matrka AK. Randomized prospective trial comparing the use of intravenous versus oral acetaminophen in total joint arthroplasty. J Arthroplasty. 2017;32(4):1125\u20137.","journal-title":"J Arthroplasty"},{"issue":"5","key":"6442_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/03007995.2017.1297702","volume":"33","author":"RN Hansen","year":"2017","unstructured":"Hansen RN, Pham AT, Boing EA, Lovelace B, Wan GJ, Miller TE. Comparative analysis of length of stay, hospitalization costs, opioid use, and discharge status among spine surgery patients with postoperative pain management including intravenous versus oral acetaminophen. Curr Med Res Opin. 2017;33(5):943\u20138.","journal-title":"Curr Med Res Opin"},{"key":"6442_CR14","unstructured":"Wien PJ, Derry S, Moore RA, McNicol ED, Bell RF, Carr DB, et al. Oral paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev. 2017;(7):CD012637."},{"issue":"2","key":"6442_CR15","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58\u201368.","journal-title":"Lancet Oncol"},{"issue":"16","key":"6442_CR16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1200\/JCO.2013.52.8356","volume":"32","author":"J Vardy","year":"2014","unstructured":"Vardy J, Agar M. Nonopioid drugs in the treatment of cancer pain. J Clin Oncol. 2014;32(16):1677\u201390. https:\/\/doi.org\/10.1200\/JCO.2013.52.8356 Epub 2014 May 5. Review. PubMed ID: 24799483.","journal-title":"J Clin Oncol"},{"issue":"suppl2","key":"6442_CR17","doi-asserted-by":"publisher","first-page":"e6944","DOI":"10.5867\/\/medwave.2017.6944","volume":"17","author":"O Corsi","year":"2017","unstructured":"Corsi O, Perez-Cruz PE. \u00bfSirve agregar paracetamol a opioides fuertes en pacientes con dolor oncol\u00f3gico? Medwave. 2017;17(suppl2):e6944. https:\/\/doi.org\/10.5867\/\/medwave.2017.6944.","journal-title":"Medwave"},{"issue":"8","key":"6442_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/026921630301700816","volume":"17","author":"B Axelsson","year":"2003","unstructured":"Axelsson B, Borup S. Is there an additive analgesic effect of paracetamol at step 3? A double-blind randomized controlled study. Palliat Med. 2003;17(8):724\u20135.","journal-title":"Palliat Med"},{"issue":"3","key":"6442_CR19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jpainsymman.2009.07.008","volume":"39","author":"FJ Israel","year":"2010","unstructured":"Israel FJ, Parker G, Charles M, Reymond L. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage. 2010;39(3):548\u201354.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"6442_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00520-009-0649-8","volume":"18","author":"DI Cubero","year":"2010","unstructured":"Cubero DI, del Giglio A. Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study. Support Care Cancer. 2010;18(2):235\u201342.","journal-title":"Support Care Cancer"},{"issue":"12","key":"6442_CR21","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00520-009-0612-8","volume":"17","author":"B Tasmacioglu","year":"2009","unstructured":"Tasmacioglu B, Aydinli I, Keskinbora K, Pekel AF, Salihoglu T, Sonsuz A. Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control. Support Care Cancer. 2009;17(12):1475\u201381.","journal-title":"Support Care Cancer"},{"issue":"16","key":"6442_CR22","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1200\/JCO.2004.09.122","volume":"22","author":"M Stockler","year":"2004","unstructured":"Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol. 2004;22(16):3389\u201394.","journal-title":"J Clin Oncol"},{"key":"6442_CR23","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Derry S, Moore RA, McNicol ED, Carr DB, Mclntyre M, et al. Oral Paracetamol (acetaminophen) for cancer pain (Review). Cochrane Database Syst Rev. 2017;(7):CD012637.","DOI":"10.1002\/14651858.CD012637"},{"key":"6442_CR24","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. https:\/\/doi.org\/10.1136\/bmj.c332 PubMed ID: 20332509.","journal-title":"BMJ"},{"key":"6442_CR25","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. https:\/\/doi.org\/10.1136\/bmj.e7586.","journal-title":"BMJ"},{"issue":"6","key":"6442_CR26","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1244::AID-CNCR26>3.0.CO;2-4","volume":"83","author":"A Vigano","year":"1998","unstructured":"Vigano A, Bruera E, Suarez-Almazor M. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer. 1998;83(6):1244\u201350.","journal-title":"Cancer"},{"issue":"17","key":"6442_CR27","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1002\/cncr.29437","volume":"121","author":"D Hui","year":"2015","unstructured":"Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA, et al. Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: a prospective, multicenter study. Cancer. 2015;121(17):3027\u201335. https:\/\/doi.org\/10.1002\/cncr.29437 Epub 2015 Jun 8. PubMed ID: 26059846.","journal-title":"Cancer"},{"issue":"6","key":"6442_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0022-3999(00)00102-1","volume":"48","author":"M Johnston","year":"2000","unstructured":"Johnston M, Pollard B, Hennessey P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res. 2000;48(6):579\u201384 PubMed ID: 11033377.","journal-title":"J Psychosom Res"},{"issue":"6","key":"6442_CR29","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.jpainsymman.2017.02.005","volume":"53","author":"PE P\u00e9rez-Cruz","year":"2017","unstructured":"P\u00e9rez-Cruz PE, Padilla P\u00e9rez O, Bonati P, Thomsen Parisi O, Tupper Satt L, Gonzalez Otaiza M, et al. Validation of the Spanish version of the Quality of Dying and Death Questionnaire (QODD-ESP) in a home-based cancer palliative care program and development of the QODD-ESP-12. J Pain Symptom Manage. 2017;53(6):1042\u20131049.e3. https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.02.005 Epub 2017 Mar 16. PubMed ID: 28323080.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"6442_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","volume":"88","author":"JT Farrar","year":"2000","unstructured":"Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000;88(3):287\u201394. https:\/\/doi.org\/10.1016\/S0304-3959(00)00339-0 PubMed ID: 11068116.","journal-title":"Pain"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06442-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T07:03:05Z","timestamp":1657090985000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06442-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6442"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06442-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"31 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the local ethics committee, Ethics committee of health sciences of Pontificia Universidad Cat\u00f3lica de Chile (CEC-SaludUC). Approval ID number: 180328004. Informed consent will be obtained from all study participants prior to enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"548"}}